BMS-561390, formerly known as DPC-083, is a reverse transcriptase inhibitor potentially for the treatment of HIV infection. References: Li S, Ma JA. Core-structure-inspired asymmetric addition reactions: enantioselective synthesis of dihydrobenzoxazinone- and dihydroquinazolinone-based anti-HIV agents. Chem Soc Rev. 2015 Nov 7;44(21):7439-48. doi: 10.1039/c5cs00342c. Review. PubMed PMID: 26177889.

纯度：≥98%

CAS：214287-99-7